Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-17), PT Metro Healthcare Indonesia Tbk's 3-1 Month Momentum % is 4.93%.
ISX:CARE's 3-1 Month Momentum % is ranked better than 62.22% of 675
companies
in the Healthcare Providers & Services industry
Industry Median: 1.18
vs ISX:CARE: 4.93
PT Metro Healthcare Indonesia Tbk (ISX:CARE) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
PT Metro Healthcare Indonesia Tbk 3-1 Month Momentum % Related Terms
ISX:CARE vs HCA, THC, EHC: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's 3-1 Month Momentum % falls into.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a 3-1 Month Momentum % of 4.93% as of Sep. 17, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #255 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 37.8%.
Is PT Metro Healthcare Indonesia Tbk's 3-1 Month Momentum % too high?
PT Metro Healthcare Indonesia Tbk's current 3-1 Month Momentum % is 4.93%. The Healthcare Providers & Services industry median 3-1 Month Momentum % is 1.18. PT Metro Healthcare Indonesia Tbk's value of 4.93% is 317.8% above this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #255 out of 675 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #255 out of 675 companies for 3-1 Month Momentum %. This puts PT Metro Healthcare Indonesia Tbk in the upper half of its industry. The industry median 3-1 Month Momentum % is 1.18. PT Metro Healthcare Indonesia Tbk's value of 4.93% is 317.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 1.18, based on 675 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current 3-1 Month Momentum % of 4.93% is 317.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 1.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current 3-1 Month Momentum % is 4.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Fairly Valued. The stock's GF Value™ is Rp370.90, compared to a current price of Rp398.00 — trading 7.3% above its estimated fair value. The current 3-1 Month Momentum % is 4.93% and 317.8% above the Healthcare Providers & Services industry median of 1.18. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current 3-1 Month Momentum % is 4.93% as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp398.00 is trading 7.3% above its estimated GF Value™ of Rp370.90.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Fairly Valued.
Key valuation signals for ISX:CARE:
3-1 Month Momentum %: 4.93%
GF Value™: Rp370.90 vs. price of Rp398.00 (7.3% above fair value)
Industry Position: 317.8% above the Healthcare Providers & Services median (#255 of 675)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
67GF Score
Get the complete analysis for ISX:CARE
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
